Trump’s approach to lowering drug costs is raising questions
The list of 2027 Medicare price negotiations includes popular GLP-1 medications used to treat obesity and diabetes.
Search Roll Call
Search the Roll Call archive by keyword, date, Congress, section, or tags.
24 results for "1"
Senators: It’s time to reclaim your relevance
And so it was last month with House passage, by a vote of 215-214, of HR 1, "The One Big Beautiful Bill Act," with all the usual self-congratulatory huzzahs without a hint of awareness of the historical
How RFK Jr. drove mistrust of a cancer prevention vaccine
He argues in most cases it can be prevented through regular pap smears and points out that less than 1 percent of women will get that cancer, which is highly treatable.
Future of Medicare drug price negotiations murky under Trump
The Biden administration said those negotiated prices, which take effect Jan. 1, 2026, would have saved Medicare $6 billion if they were in effect last year.
Harris’ Senate portfolio included maternal health, telehealth
Biden administration’s push for states to expand Medicaid postpartum coverage from two to 12 months, creating "birthing friendly" hospital designations and launching the maternal mental health hotline (1-
HHS lists first 10 drugs subject to Medicare price negotiation
New prices take effect Jan. 1, 2026.
Congress · 117th Congress
After four-hour debate, Senate begins voting on budget bill amendments
Kyrsten Sinema, D-Ariz., including adjustments to a 15 percent corporate minimum tax based on income reported to shareholders, a 1 percent tax on companies’ stock buybacks and $4 billion for drought relief
Congress · 117th Congress
Groups launch last-ditch effort against drug pricing changes
It recently announced a $1 million ad buy to run on D.C.-area cable channels from July 1 through Aug. 5.
Congress · 117th Congress
With Senate readying vote on insulin bill, advocates seek changes
and hopefully we can make it so that it’s going to have the biggest impact for the most people,” said Shaina Kasper, policy manager for T1International, a nonprofit that advocates for people with Type 1
Opinion · 117th Congress
Democrats have few answers on ending losing streak after Manchin’s reconciliation dagger
But on student debt relief, the White House has been firm that payments must resume Feb. 1. Senate Majority Leader Charles E.
Congress · 117th Congress
Democrats to meet on budget as moderate holdouts face pressure
DeFazio followed up in a Monday letter to colleagues committing to pass the Senate’s infrastructure bill by Oct. 1, when current surface transportation authorizations expire.
Campaigns · 117th Congress
Health care divisions persist in key Democratic Senate primary
Biden, who was in Wisconsin on Tuesday to tout a bipartisan infrastructure package, carried the Badger State by less than 1 percentage point last year. GOP Sen.
Opinion · 117th Congress
Animal testing is cruel and often unnecessary. But the FDA forces drugmakers to do it
As White Coat Waste Project has documented, in some of the standard tests the FDA compels companies to conduct, puppies as young as 1 week old are forced to ingest massive doses of experimental drugs,
Policy · 116th Congress
Virus vaccination timeline depends on variety of factors
[jwp-video n=”1″] Number of doses and timing Vaccinating about 60 to 70 percent of the approximately 333 million U.S. residents — the percentage experts estimate need to be vaccinated in order
Policy · 116th Congress
COVID-19 trials risk excluding those most vulnerable to virus
[jwp-video n=”1″]
Policy · 116th Congress
FDA releases high coronavirus vaccine standards despite White House resistance
At the presidential debate in Cleveland last week, Trump said it’s possible there would be results before Nov. 1 and that “we’re going to deliver it right away.”
Policy · 116th Congress
Internal documents show drugmakers’ reliance on US price hikes
The hearings culminated from 18 months of investigations involving more than 1 million pages of company documents, the committee said.
Campaigns · 116th Congress
The legislative record of Kamala Harris shows a loyal Democrat and Trump counterpuncher
[jwp-video n=”1″] Health care Harris went back and forth on her support for “Medicare for All” last year during her presidential run, which was a key policy debate throughout the Democratic
Policy · 116th Congress
Experts: Public trust in science, data key to COVID-19 vaccine credibility
[jwp-video n=”1″]
Policy · 116th Congress
Corporations and consumer groups battle over COVID-19 liability
[jwp-video n=”1″] President Donald Trump said Tuesday he supports “curbs on frivolous litigation … a thing I know something about. There’s a lot of frivolous litigation.”